Clinical Trial Update: Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating short-term exposure to lipophilic anti-proliferative drugs delivered via angiographic contrast media in coronary artery dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: University Hospital, Saarland | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: COMPLETED